THE GOVERNMENT OF THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES has a total of 32 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Canada and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are UNIV OSAKA RES FOUND, DNATRIX INC and SCHWEITZER CHEMICAL CORP USA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | Canada | 10 | |
#3 | Brazil | 4 | |
#4 | Hong Kong | 2 | |
#5 | Australia | 1 | |
#6 | Hungary | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Organic fine chemistry | |
#7 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials | |
#8 | Electrotherapy | |
#9 | Enzymes | |
#10 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lai Ching-Juh | 5 |
#2 | Whitehead Stephen S | 5 |
#3 | Murphy Brian R | 5 |
#4 | Jiang Baoming | 4 |
#5 | Hanley Kathryn | 3 |
#6 | Blaney Joseph | 3 |
#7 | Markoff Lewis | 3 |
#8 | Falgout Barry | 3 |
#9 | Brian R Murphy | 2 |
#10 | Wang Yuhuan | 2 |
Publication | Filing date | Title |
---|---|---|
EP3006565A1 | Selective detection of bordetella parapertussis | |
EP3351628A1 | Human ebola virus species and compositions and methods thereof | |
CA2726131A1 | Expression and assembly of human group c rotavirus-like particles and uses thereof | |
EP3799874A1 | N-acetyl mannosamine for the treatment of diabetes involving proteinuria | |
CA2614072A1 | Systems and methods for recovery of motor control via stimulation to a substituted site for an affected area | |
BRPI0413309A | Method for the preparation of a polysaccharide-protein conjugate vaccine | |
BRPI0309631A8 | tetravalent dengue vaccine containing a trivial deletion of 30 nucleotides in the utr-31 'of dengue types 1,2,3 and 4, or chimeric dengue antigenic viruses 1,2,3 and 4 |